Format

Send to

Choose Destination
J Neurol. 2011 Jan;258(1):14-8. doi: 10.1007/s00415-010-5746-6. Epub 2010 Sep 18.

Current approach to seronegative myasthenia.

Author information

1
Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. zohara@ekmd.huji.ac.il

Abstract

The group of patients with weakness or fatigue who have electrophysiological evidence of neuromuscular transmission defects, but no antibodies against either acetyl choline receptor or muscle specific kinase, need special evaluation and therapeutic consideration. Such seronegative patients may have low affinity antibodies but may also be late onset of a congenital myasthenic syndrome. This review discuss the practical approach toward the condition of seronegative myasthenia.

PMID:
20852878
DOI:
10.1007/s00415-010-5746-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center